Terns Pharmaceuticals, Inc.

TERN · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$150,698$145,966$139,023$161,439
Short-Term Investments$144,937$169,479$195,241$196,725
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$4,660$3,507$3,484$3,945
Total Curr. Assets$300,295$318,952$337,748$362,109
Property Plant & Equip (Net)$997$1,107$1,216$1,470
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$359$356$351$350
Total NC Assets$1,356$1,463$1,567$1,820
Other Assets$0$0$0$0
Total Assets$301,651$320,415$339,315$363,929
Liabilities
Payables$2,946$2,849$2,778$2,148
Short-Term Debt$459$444$429$428
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$11,982$9,621$7,728$13,074
Total Curr. Liab.$15,387$12,914$10,935$15,650
LT Debt$570$689$806$919
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$1,628$1,583$1,531$1,490
Total NC Liab.$2,198$2,272$2,337$2,409
Other Liabilities$0$0$0$0
Cap. Leases$1,029$1,133$1,235$1,347
Total Liabilities$17,585$15,186$13,272$18,059
Equity
Pref Stock$0$0$0$0
Common Stock$9$9$9$9
Retained Earnings-$494,117-$469,482-$445,389-$421,481
AOCI$109-$22$51-$279
Other Equity$778,065$774,724$771,372$767,621
Total Equity$284,066$305,229$326,043$345,870
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$301,651$320,415$339,315$363,929
Net Debt-$149,669-$144,833-$137,788-$160,092